Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Platforms, advances, and technical challenges in virus-like particles-based vaccines
Reeshu Gupta, Kajal Arora, Sourav Singha Roy, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 54

Showing 26-50 of 54 citing articles:

A subunit vaccine based on P97R1, P46, P42, and P65 from Mycoplasma hyopneumoniae can induce significant immune response in piglets
Yintao He, Kaiyuan Xie, Zhongmao Yuan, et al.
Frontiers in Veterinary Science (2024) Vol. 11
Open Access | Times Cited: 1
From organ preservation to selective surgery: How immunotherapy changes colorectal surgery?
Shiya Yao, Huanrong Lan, Yuejun Han, et al.
Surgery Open Science (2023) Vol. 15, pp. 44-53
Open Access | Times Cited: 4
Virus-like particles (VLPs)-based vaccines against COVID-19: Where do we stand amid the ongoing evolution of SARS-CoV-2?
Manish Dhawan, AbdulRahman A. Saied, Manish Sharma
Health Sciences Review (2023) Vol. 9, pp. 100127-100127
Open Access | Times Cited: 4
Biomimetic Nanovaccines: A Novel Approach in Immunization
Javad Yaghmoorian Khojini, Benjamin Babaei, Maryam Shakarami, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 18, pp. 1391-1408
Closed Access | Times Cited: 3
Virus-like Particles Based on the Novel Goose Parvovirus (NGPV) VP2 Protein Protect Ducks against NGPV Challenge
Yu Shang, Yao Ma, Sheng Tang, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1768-1768
Open Access | Times Cited: 2
Challenges and Opportunities in the Process Development of Chimeric Vaccines
Shivani Chauhan, Yogender Pal Khasa
Vaccines (2023) Vol. 11, Iss. 12, pp. 1828-1828
Open Access | Times Cited: 2
Serological characterisation of Lagovirus virus-like particles originating from native and mutated VP60 of rabbit haemorrhagic disease virus 2 and European brown hare syndrome virus
Martyna Krejmer-Rąbalska, Marta Peplińska, Bogusław Szewczyk, et al.
Journal of Veterinary Research (2024) Vol. 68, Iss. 1, pp. 9-17
Open Access
The effects of high shear rates on the average hydrodynamic diameter measured in biomimetic HIV Gag virus-like particle dispersions
Tobias Wolf, Kerim Kadir Calisan, Jörn Stitz, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access
The Potential of Plant-Produced Virus-like Particle Vaccines for African Horse Sickness and Other Equine Orbiviruses
Kieran G. Pitchers, Oliver D. Boakye, Ivan Campeotto, et al.
Pathogens (2024) Vol. 13, Iss. 6, pp. 458-458
Open Access
Challenges in the Analytical Characterization of VLPs Through HPLC-Based Methods
Anurag S. Rathore, Vineela Peruri, Jared R. Auclair
Deleted Journal (2024), pp. 14-18
Open Access
Efficacy comparison in cap VLPs of PCV2 and PCV3 as swine vaccine vehicle
He Qiu, Meiqi Sun, Nan Wang, et al.
International Journal of Biological Macromolecules (2024) Vol. 278, pp. 134955-134955
Closed Access
Enhancing NA immunogenicity through novel VLP designs.
Leticia Guzman Ruiz, Alexander M Zollner, Irene Hoxie, et al.
Vaccine (2024) Vol. 42, Iss. 24, pp. 126270-126270
Open Access
Significance of VLPs in Vlp-circRNA vaccines: a vaccine candidate or delivery vehicle?
Reeshu Gupta, Kajal Arora, Nupur Mehrotra Arora, et al.
RNA Biology (2024) Vol. 21, Iss. 1, pp. 17-28
Open Access
Virus-like particles in poultry disease: an approach to effective and safe vaccination
Abdullahi Abdullahi Raji, Paniz Zarghami Dastjerdi, Abdul Rahman Omar
Frontiers in Veterinary Science (2024) Vol. 11
Open Access
A self-adjuvanted VLPs-based Covid-19 vaccine proven versatile, safe, and highly protective
Larissa Vuitika, Nelson Côrtes, Vanessa Barbosa Malaquias, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Preparation of bovine coronavirus virus-like particles and its immunogenicity in mice and cattle
Qisheng Yu, Qing Zhu, Xiangyue Huang, et al.
Microbial Pathogenesis (2024), pp. 107062-107062
Closed Access
Dimming the corona: studying SARS-coronavirus-2 at reduced biocontainment level using replicons and virus-like particles
Grace Neilsen, Asha Maria Mathew, J.M. Castro, et al.
mBio (2024)
Open Access
MULTIFACETED VIRUS-LIKE PARTICLES: NAVIGATING TOWARDS BROADLY EFFECTIVE INFLUENZA A VIRUS VACCINES
Jaffar Ali Muhamad Norizwan, Wen Siang Tan
Current Research in Microbial Sciences (2024) Vol. 8, pp. 100317-100317
Open Access
Current Advances in Viral Nanoparticles for Biomedicine
Xianxun Sun, Tao Tian, Yindong Lian, et al.
ACS Nano (2024)
Closed Access
Potentiating Virus-like Particles for Mucosal Vaccination Using Material Science Approaches
Milad Radiom
Colloids and Interfaces (2024) Vol. 8, Iss. 6, pp. 68-68
Open Access
Mitochondrial transcription elongation factor TEFM promotes malignant progression of gliomas
Yin Wang, Wenxuan Hu, Boya Zhou, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access
Immunogenicity and safety of SARS-CoV-2 recombinant protein vaccine (CHO cell) LYB001 as a heterologous booster following two- or three-dose inactivated COVID-19 vaccine in adults aged ≥18 years: interim results of a randomized, active-controlled, double-blinded, phase 3 trial
Beifang Yang, Jing Jin, Xiran He, et al.
Expert Review of Vaccines (2024)
Open Access
Cancer vaccines: an update on recent achievements and prospects for cancer therapy
Arezki Chekaoui, Mariangela Garofalo, Beata Gad, et al.
Clinical and Experimental Medicine (2024) Vol. 25, Iss. 1
Open Access
Enzyme-linked immunosorbent assay to determine the potency of a rotavirus vaccine based on virus-like particles: analytical procedure development and validation
Ilya E. Filatov, M. M. Silaenkova, Tsibezov Vv, et al.
Biological Products Prevention Diagnosis Treatment (2024) Vol. 24, Iss. 4, pp. 389-402
Open Access
Design of Novel Vaccines Based on Virus-Like Particles
Juan Bárcena, María Zamora-Ceballos, Esther Blanco
Sub-cellular biochemistry/Subcellular biochemistry (2024), pp. 785-821
Closed Access

Scroll to top